Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://www.jocmr.org

Original Article

Volume 5, Number 3, June 2013, pages 217-221

Factors Associated With Reduced Efficacy of Sitagliptin Therapy: Analysis of 93 Patients With Type 2 Diabetes Treated for 1.5 Years or Longer

Figures

Figure 1.
Figure 1. Changes of HbA1c (NGSP).
Figure 2.
Figure 2. Comparison of groups with stable or increasing HbA1c levels.
Figure 3.
Figure 3. Relationship between the changes of body weight and HbA1c from 24 to 48 weeks after the start of sitagliptin therapy.
Figure 4.
Figure 4. Compliance with diet/exercise therapy at 48 weeks after the start of sitagliptin treatment.
Figure 5.
Figure 5. Factors related to a ≥ 0.3% increase of HbA1c from 24 to 48 weeks after starting sitagliptin treatment.